Question 1

What is KRYS's ST Score?

Accepted Answer

Krystal Biotech, Inc. (KRYS) has an ST Score of 62.6 out of 100, an overall grade of B. The ST Score combines eight factor grades — valuation, profitability, financial strength, momentum, growth, forecast, sentiment and Piotroski — into a single A+ to F rating.

Question 2

Is KRYS a buy, sell, or hold?

Accepted Answer

Wall Street's consensus rating on KRYS is Buy based on 17 analyst ratings. Our own ST Score grades it B (62.6/100). This is data, not investment advice — always do your own research.

Question 3

What is KRYS's valuation grade?

Accepted Answer

Krystal Biotech, Inc. (KRYS) earns a valuation grade of F, measured against Biotechnology peers. The valuation factor looks at multiples such as P/E, P/S, P/B, EV/EBITDA and free cash flow yield.

Question 4

What is KRYS's growth grade?

Accepted Answer

Krystal Biotech, Inc. (KRYS) earns a growth grade of B+, measured against Biotechnology peers. The growth factor looks at revenue, earnings and cash flow growth over recent quarters and years.

Question 5

What is KRYS's profitability grade?

Accepted Answer

Krystal Biotech, Inc. (KRYS) earns a profitability grade of A+, measured against Biotechnology peers. The profitability factor looks at margins and returns such as gross margin, net margin, ROE and ROIC.

Question 6

What is KRYS's financial strength grade?

Accepted Answer

Krystal Biotech, Inc. (KRYS) earns a financial strength grade of A-, measured against Biotechnology peers. The financial strength factor looks at debt levels, liquidity and coverage ratios.

Question 7

What is the analyst price target for KRYS?

Accepted Answer

The average analyst price target for Krystal Biotech, Inc. (KRYS) is $383.75 from 17 analysts, which is +0.1% versus the recent price of $333.85.

Question 8

What is KRYS's Piotroski score?

Accepted Answer

Krystal Biotech, Inc. (KRYS) has a Piotroski F-Score of 5 out of 9. The Piotroski score checks nine accounting signals covering profitability, leverage and operating efficiency; scores of 8–9 are considered strong and 0–2 weak.

Krystal Biotech, Inc. (KRYS) Ownership — Institutional & Insider Holdings

What is institutional ownership of a stock?

How do I check institutional ownership for KRYS?

Is high institutional ownership good for a stock?

What does insider activity tell you about KRYS?

What is the current Krystal Biotech, Inc. (KRYS) stock price?

What sector and industry does KRYS operate in?

What is KRYS's market cap?

How many employees does KRYS have?